Teraplast (TRP) investor relations material

Executive summary

• Turnover rose 29% year-over-year to 552 million lei in H1 2025, with EBITDA up 74% to 47 million lei and net profit of 3.4 million lei, reversing a prior loss despite 4.3 million lei in forex losses.

• International sales nearly doubled, now 35% of turnover, driven by market demand, M&A, and operational efficiency.

• Integration of acquisitions, especially Aquatica Experience, Wolfgang Freiler Group, and Optiplast, contributed significantly to growth.

• Growth supported by volume increases and new business lines, despite packaging challenges and price deflation.

• Conservative outlook maintained due to uncertainty in Romanian infrastructure investments.

Financial highlights

• EBITDA margin improved to 8.5% (up 2.2pp year-over-year); gross margin rose to 37%.

• Operating income increased 30%, while operating costs rose 27%.

• Turnover and EBITDA exceeded budget by 13% and 12%, respectively.

• Volumes increased 18% year-over-year, with Installations and Compounds up 12%.

• Cash at period end was 24.1 million lei, down from 32.4 million at the start of the year.

Outlook and guidance

• External sales now 35% of turnover, supporting strategy to reduce Romanian market dependency.

• Management maintains a conservative full-year outlook due to uncertainty in infrastructure investment pace, with a potential revision after Q3.

• Leverage ratio projected to fall below 4 by year-end 2025, supported by EBITDA growth.

• Results from investments in Hungary, Austria, and Germany expected from next year.

• Continued focus on international expansion and integration of recent acquisitions.